Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I V Ulasov

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Letters|May 1, 2018
Autophagy in glioma cells: An identity crisis with a clinical perspectiveI V Ulasov, G Lenz, M S Lesniak
Genes & Diseases|February 17, 2015
Oncolytic adenoviruses: A thorny path to glioma cureI V Ulasov, A V Borovjagin, B A Schroeder, et al.
British Journal of Cancer|March 12, 2009
Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivoI V Ulasov, A M Sonabend, S Nandi, et al.
Gene Therapy|June 8, 2012
Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradationB Thaci, I V Ulasov, A U Ahmed, et al.
Cancer Gene Therapy|May 5, 2012
Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor modelB Thaci, A U Ahmed, I V Ulasov, et al.
Gene Therapy|December 17, 2008
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivoM A Tyler, I V Ulasov, A M Sonabend, et al.
Cancer Gene Therapy|November 18, 2008
Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton ratsA M Sonabend, I V Ulasov, Y Han, et al.
International Journal of Nanoscience|October 30, 2012
MULTIFUNCTIONAL NANO-BIO MATERIALS WITHIN CELLULAR MACHINERYE A Rozhkova, I V Ulasov, D-H Kim, et al.
Cancer Gene Therapy|January 18, 2014
Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant gliomaB Thaci, A U Ahmed, I V Ulasov, et al.
Cancer Biology & Therapy|August 30, 2008
Characterization of infectivity of knob-modified adenoviral vectors in gliomaC P L Paul, M Everts, J N Glasgow, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Letters|May 1, 2018
Autophagy in glioma cells: An identity crisis with a clinical perspectiveI V Ulasov, G Lenz, M S Lesniak
Genes & Diseases|February 17, 2015
Oncolytic adenoviruses: A thorny path to glioma cureI V Ulasov, A V Borovjagin, B A Schroeder, et al.
British Journal of Cancer|March 12, 2009
Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivoI V Ulasov, A M Sonabend, S Nandi, et al.
Gene Therapy|June 8, 2012
Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradationB Thaci, I V Ulasov, A U Ahmed, et al.
Cancer Gene Therapy|May 5, 2012
Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor modelB Thaci, A U Ahmed, I V Ulasov, et al.
Gene Therapy|December 17, 2008
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivoM A Tyler, I V Ulasov, A M Sonabend, et al.
Cancer Gene Therapy|November 18, 2008
Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton ratsA M Sonabend, I V Ulasov, Y Han, et al.
International Journal of Nanoscience|October 30, 2012
MULTIFUNCTIONAL NANO-BIO MATERIALS WITHIN CELLULAR MACHINERYE A Rozhkova, I V Ulasov, D-H Kim, et al.
Cancer Gene Therapy|January 18, 2014
Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant gliomaB Thaci, A U Ahmed, I V Ulasov, et al.
Cancer Biology & Therapy|August 30, 2008
Characterization of infectivity of knob-modified adenoviral vectors in gliomaC P L Paul, M Everts, J N Glasgow, et al.
Pageof 1